HUMAN GENOME SCIENCES INC Interest Paid, Including Capitalized Interest, Operating and Investing Activities
HUMAN GENOME SCIENCES INC reported Interest Paid, Including Capitalized Interest, Operating and Investing Activities of $22.63 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-07-26.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:InterestPaid · last filed 2012-07-26
- HUMAN GENOME SCIENCES INC interest paid, including capitalized interest, operating and investing activities for the quarter ending 2012-06-30 was $14.04M, a 67.15% increase year-over-year.
- HUMAN GENOME SCIENCES INC interest paid, including capitalized interest, operating and investing activities for the quarter ending 2012-03-31 was $8.58M, a 1.97% increase year-over-year.
- HUMAN GENOME SCIENCES INC interest paid, including capitalized interest, operating and investing activities for the quarter ending 2011-12-31 was $7.14M, a 13.80% decline year-over-year.
- HUMAN GENOME SCIENCES INC interest paid, including capitalized interest, operating and investing activities for the quarter ending 2011-09-30 was $8.59M, a 2.30% increase year-over-year.
- HUMAN GENOME SCIENCES INC interest paid, including capitalized interest, operating and investing activities for fiscal 2011 was $32.55M, a 1.88% decline from fiscal 2010.
- HUMAN GENOME SCIENCES INC interest paid, including capitalized interest, operating and investing activities for fiscal 2010 was $33.17M, a 1.31% decline from fiscal 2009.
- HUMAN GENOME SCIENCES INC interest paid, including capitalized interest, operating and investing activities for fiscal 2009 was $33.61M.
| Period end | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 3 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 6 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 9 month | Interest Paid, Including Capitalized Interest, Operating and Investing Activities 12 month |
|---|---|---|---|---|
| 2012-06-30 | $14.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $22.63M 10-Q · filed 2012-07-26 | $29.77M derived: sum of 3 quarters · filed 2012-07-26 | $38.35M derived: sum of 4 quarters · filed 2012-07-26 |
| 2012-03-31 | $8.58M 10-Q · filed 2012-04-26 | $15.72M derived: sum of 2 quarters · filed 2012-04-26 | $24.31M derived: sum of 3 quarters · filed 2012-04-26 | $32.71M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-12-31 | $7.14M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $15.73M derived: sum of 2 quarters · filed 2012-02-28 | $24.13M derived: sum of 3 quarters · filed 2012-07-26 | $32.55M 10-K · filed 2012-02-28 |
| 2011-09-30 | $8.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $16.99M derived: sum of 2 quarters · filed 2012-07-26 | $25.41M 10-Q · filed 2011-10-28 | $33.69M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-06-30 | $8.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-26 | $16.82M 10-Q · filed 2012-07-26 | $25.10M derived: sum of 3 quarters · filed 2012-07-26 | $33.50M derived: sum of 4 quarters · filed 2012-07-26 |
| 2011-03-31 | $8.42M 10-Q · filed 2012-04-26 | $16.70M derived: sum of 2 quarters · filed 2012-04-26 | $25.09M derived: sum of 3 quarters · filed 2012-04-26 | $33.30M derived: sum of 4 quarters · filed 2012-04-26 |
| 2010-12-31 | $8.28M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-28 | $16.68M derived: sum of 2 quarters · filed 2012-02-28 | $24.89M derived: sum of 3 quarters · filed 2012-02-28 | $33.17M 10-K · filed 2012-02-28 |
| 2010-09-30 | $8.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-28 | $16.60M derived: sum of 2 quarters · filed 2011-10-28 | $24.89M 10-Q · filed 2011-10-28 | |
| 2010-06-30 | $8.21M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-07-28 | $16.49M 10-Q · filed 2011-07-28 | ||
| 2010-03-31 | $8.28M 10-Q · filed 2011-04-29 | |||
| 2009-12-31 | $33.61M 10-K · filed 2012-02-28 |